FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092251671> ?p ?o ?g. }

• W2092251671 endingPage "332" @default.
• W2092251671 startingPage "331" @default.
• W2092251671 abstract "HomeCirculation ResearchVol. 101, No. 4ecSOD Controls the Delicate Balance of Reactive Oxygen Species in Bone Marrow and Ischemic Tissue Needed for Neovascularization Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBecSOD Controls the Delicate Balance of Reactive Oxygen Species in Bone Marrow and Ischemic Tissue Needed for Neovascularization Michael S. Wolin Michael S. WolinMichael S. Wolin From the Departments of Physiology, New York Medical College, Valhalla, NY. Search for more papers by this author Originally published17 Aug 2007https://doi.org/10.1161/CIRCRESAHA.107.101161Circulation Research. 2007;101:331–332“In this issue of Circulation Research, Tohru Fukai and colleagues (1) provide evidence from a mouse hindlimb ischemia model indicating that the superoxide anion scavenging activity of the secreted extracellular form of superoxide dismutase (ecSOD) has an apparently essential role in enabling neovascularization to occur.” Both reactive oxygen species (ROS) and nitric oxide (NO) appear to be part of many of the signaling mechanisms in individual cell types and subcellular environments influencing key processes (shown in the Figure) that both enable and prevent the restoration of impaired blood flow to ischemic tissue through neovascularization. Thus, it seems rather remarkable that the ecSOD system has such an important role in controlling the balance of processes involved. Moreover, ecSOD appears to be a key regulator of the mobilization of circulating inflammatory and endothelial progenitor cells (EPCs) from bone marrow, which are major contributors to inflammation driven vascular growth promoting processes involved in neovascularization. Download figureDownload PowerPointModel showing the potential role of an increase in ecSOD caused by hindlimb ischemia in modulating ROS and NO-derived species and processes potentially regulated by changes in the balance of redox signaling that potentially contribute to the reparative neovascularization based on studies in mice deficient in ecSOD.Hindlimb ischemia is shown in the Fukai study to increase the expression of ecSOD both in the ischemic muscle tissue and in bone marrow. The importance of this observation is highlighted by data showing that exposure of mice deficient in ecSOD to hindlimb ischemia was associated with decreased NO-cGMP signaling in both the ischemic skeletal muscle and bone marrow, suggesting that the well established role of ecSOD in protecting NO signaling is likely to be an important factor.2 Some of the key processes associated with neovascularization, including the mobilization of EPCs3 and angiogenesis,4 are thought to be regulated by NO. In addition, the gp91phox or Nox2-containing NAD(P)H oxidase appears to have an important role in the angiogenesis in response to hindlimb ischemia.5 This suggests that the superoxide anion and peroxynitrite (ONOO−) lowering and hydrogen peroxide increasing actions of ecSOD may also be a contributing factor. The observation that ecSOD expression is increased in the region of macrophages in ischemic tissue also suggests that it may function to shift the balance of radical-related species in the extracellular environment toward NO and peroxide. Peroxide appears to be involved in promoting growth of endothelial and vascular smooth muscle cells. As we look further into the potential actions of the balance between ROS and NO-derived species, inhibition of growth and apoptosis are factors to consider. Indeed, increased apoptosis was observed in the ecSOD-deficient hindlimb ischemia model.1 Observations that a low dose of a SOD mimetic (tempol) essentially reversed the effects of a deficiency of ecSOD, further support the key role of the superoxide anion metabolizing activity of this enzyme in the protective effects observed. Thus, it seems quite remarkable that metabolism of superoxide anion by ecSOD in the extracellular region has such an important role of maintaining the balance in ROS-NO signaling needed for neovascularization processes (shown in the Figure).Based on the observations of improved biosynthesis of nitrite and nitrate decomposition products of NO, one of the actions ecSOD appears to be preventing a decrease in NO biosynthesis. This occurs potentially as a result of increasing nitric oxide synthase activity by hydrogen peroxide or by prevention of the loss of its cofactor tetrahydrobiopterin presumably through oxidation by ONOO−. These data suggest that ecSOD is also modulating intracellular processes regulated by ROS and their interaction with the NO system. There is substantial evidence for cellular and subcellular compartmentalization of superoxide-derived ROS regulation. If one hypothesizes how ecSOD alters the metabolism of ROS in a manner which potentially modulates neovascularization, there appear to be many ways it could influence the outcome. Processes such as inflammatory cell recruitment and activation, promoting endothelial and smooth muscle growth, modulating the effect of NO on inflammatory cell activation and vascular cell growth, as well as promoting apoptotic or necrotic cell death, are all regulated by ROS. The dramatic effects of an ecSOD deficiency on all of these processes1 highlight the biological importance of regulating the balance of individual ROS and NO-derived species.There are many observations and issues raised by the Fukai study that are likely to influence future work in this area. Beause ecSOD enhances NO signaling, this action of increased ecSOD should help promote the mobilization of circulating inflammatory and EPCs from bone marrow, and angiogenesis in ischemic tissue. However, NO is also known to have a role in inhibiting inflammatory responses and the growth of vascular smooth muscle. Thus, one could hypothesize that NO would restrain inflammatory cell recruitment and the arteriogenesis component of neovascularization. Perhaps enhancement of peroxide formation by ecSOD is also a factor in its effect on the balance of ROS regulation that permits these processes to occur. Once arteriogenesis has occurred, it seems that the endothelium-derived NO-mediated vasodilation may contribute to the increase in blood flow associated with neovascularization.6 The role of ecSOD in increasing NO and to modulate oxidative stress may also help control the balance of redox processes needed for neovascularization through feedback regulatory mechanisms that further enhance the expression of ecSOD and prevent the activation additional sources of ROS. Bone marrow transplant rescue studies in the hindlimb ischemia model1 also highlight the great importance of ROS regulation by ecSOD for the release of inflammatory cells and EPCs in the neovascularization process. Thus, observations made in this study of the effects of an ecSOD deficiency on neovascularization may contribute to developing a better understanding of sequential changes in signaling mechanisms controlled by the balance of local levels of ROS and NO-derived species which regulate processes that enable this repair mechanism to function.The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.Sources of FundingThe laboratory of the author is funded by NIH grants HL31069, HL43023, and HL66331.DisclosuresNone.FootnotesCorrespondence to Michael S. Wolin, PhD, Department of Physiology, Basic Science Building, Rm. 604, New York Medical College, Valhalla, NY 10595. E-mail [email protected] References 1 Kim HW, Lin A, Guldberg R, Ushio-Fukai M, Fukai T. Essential role of extracellular SOD in reparative neovascularization induced by hindlimb ischemia. Circ Res. 2007; 101: 409–419.LinkGoogle Scholar2 Jung O, Marklund SL, Geiger H, Pedrazzini T, Busse R, Brandes RP. Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ Res. 2003; 93: 622–629.LinkGoogle Scholar3 Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, Dimmeler S. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med. 2003; 9: 1370–1376.CrossrefMedlineGoogle Scholar4 Ahmad S, Hewett PW, Wang P, Al-Ani B, Cudmore M, Fujisawa T, Haigh JJ, le Noble F, Wang L, Mukhopadhyay D, Ahmed A. Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide–mediated angiogenesis. Circ Res. 2006; 99: 715–722.LinkGoogle Scholar5 Ushio-Fukai M. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc Res. 2006; 71: 226–235.CrossrefMedlineGoogle Scholar6 Mees B, Wagner S, Ninci E, Tribulova S, Martin S, van Haperen R, Kostin S, Heil M, de Crom R, Schaper W. Endothelial nitric oxide synthase activity is essential for vasodilation during blood flow recovery but not for arteriogenesis. Arterioscler Thromb Vasc Biol. In press.Google Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited ByKonkalmatt P, Beyers R, O’Connor D, Xu Y, Seaman M and French B (2013) Cardiac-Selective Expression of Extracellular Superoxide Dismutase After Systemic Injection of Adeno-Associated Virus 9 Protects the Heart Against Post–Myocardial Infarction Left Ventricular Remodeling, Circulation: Cardiovascular Imaging, 6:3, (478-486), Online publication date: 1-May-2013. Kim C, Kim E and Nam Y (2021) Superoxide Dismutase Multigene Family from a Primitive Chondrostean Sturgeon, Acipenser baerii: Molecular Characterization, Evolution, and Antioxidant Defense during Development and Pathogen Infection, Antioxidants, 10.3390/antiox10020232, 10:2, (232) August 17, 2007Vol 101, Issue 4 Advertisement Article InformationMetrics https://doi.org/10.1161/CIRCRESAHA.107.101161PMID: 17702978 Originally publishedAugust 17, 2007 Keywordsoxidant stressischemic biologynitric oxideendotheliumPDF download Advertisement" @default.
• W2092251671 created "2016-06-24" @default.
• W2092251671 creator A5040548588 @default.
• W2092251671 date "2007-08-17" @default.
• W2092251671 modified "2023-09-27" @default.
• W2092251671 title "ecSOD Controls the Delicate Balance of Reactive Oxygen Species in Bone Marrow and Ischemic Tissue Needed for Neovascularization" @default.
• W2092251671 cites W1988126593 @default.
• W2092251671 cites W2096188077 @default.
• W2092251671 cites W2110539420 @default.
• W2092251671 cites W2137861969 @default.
• W2092251671 cites W2170252500 @default.
• W2092251671 doi "https://doi.org/10.1161/circresaha.107.101161" @default.
• W2092251671 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17702978" @default.
• W2092251671 hasPublicationYear "2007" @default.
• W2092251671 type Work @default.
• W2092251671 sameAs 2092251671 @default.
• W2092251671 citedByCount "2" @default.
• W2092251671 countsByYear W20922516712013 @default.
• W2092251671 countsByYear W20922516712021 @default.
• W2092251671 crossrefType "journal-article" @default.
• W2092251671 hasAuthorship W2092251671A5040548588 @default.
• W2092251671 hasConcept C126322002 @default.
• W2092251671 hasConcept C142724271 @default.
• W2092251671 hasConcept C168031717 @default.
• W2092251671 hasConcept C169760540 @default.
• W2092251671 hasConcept C185592680 @default.
• W2092251671 hasConcept C2778271429 @default.
• W2092251671 hasConcept C2780007613 @default.
• W2092251671 hasConcept C2780394083 @default.
• W2092251671 hasConcept C48349386 @default.
• W2092251671 hasConcept C71924100 @default.
• W2092251671 hasConcept C86803240 @default.
• W2092251671 hasConcept C95444343 @default.
• W2092251671 hasConceptScore W2092251671C126322002 @default.
• W2092251671 hasConceptScore W2092251671C142724271 @default.
• W2092251671 hasConceptScore W2092251671C168031717 @default.
• W2092251671 hasConceptScore W2092251671C169760540 @default.
• W2092251671 hasConceptScore W2092251671C185592680 @default.
• W2092251671 hasConceptScore W2092251671C2778271429 @default.
• W2092251671 hasConceptScore W2092251671C2780007613 @default.
• W2092251671 hasConceptScore W2092251671C2780394083 @default.
• W2092251671 hasConceptScore W2092251671C48349386 @default.
• W2092251671 hasConceptScore W2092251671C71924100 @default.
• W2092251671 hasConceptScore W2092251671C86803240 @default.
• W2092251671 hasConceptScore W2092251671C95444343 @default.
• W2092251671 hasIssue "4" @default.
• W2092251671 hasLocation W20922516711 @default.
• W2092251671 hasLocation W20922516712 @default.
• W2092251671 hasOpenAccess W2092251671 @default.
• W2092251671 hasPrimaryLocation W20922516711 @default.
• W2092251671 hasRelatedWork W1970707390 @default.
• W2092251671 hasRelatedWork W1971419911 @default.
• W2092251671 hasRelatedWork W2027717767 @default.
• W2092251671 hasRelatedWork W2038751394 @default.
• W2092251671 hasRelatedWork W2067699521 @default.
• W2092251671 hasRelatedWork W2371279320 @default.
• W2092251671 hasRelatedWork W2748952813 @default.
• W2092251671 hasRelatedWork W2899084033 @default.
• W2092251671 hasRelatedWork W3032513420 @default.
• W2092251671 hasRelatedWork W74504067 @default.
• W2092251671 hasVolume "101" @default.
• W2092251671 isParatext "false" @default.
• W2092251671 isRetracted "false" @default.
• W2092251671 magId "2092251671" @default.
• W2092251671 workType "article" @default.